Technical Analysis for CNCR - Loncar Cancer Immunotherapy ETF

Grade Last Price % Change Price Change
B 30.9956 -0.88% -0.27
CNCR closed down 0.88 percent on Friday, September 24, 2021, on 86 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Up Flat
Historical CNCR trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
20 DMA Support Bullish 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction -0.88%
BB Squeeze + Upper Band Touch Range Contraction -0.88%
Upper Bollinger Band Touch Strength -0.88%
Older End-of-Day Signals for CNCR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Loncar Cancer Immunotherapy ETF Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.


Classification

Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Cancer SPDR Betashares Immune System Immunotherapy Cancer Immunotherapy Lonca Biotechnology Sectors Loncar Cancer Immunotherapy Index

Top 10 Components

Symbol Grade Price % Change Allocation
RCUS A -2.76 4.53
ALXO B -4.82 4.33
MGNX F -3.89 4.24
REGN B -1.18 4.14
TIL B 6.11 3.88
ATRA B -1.73 3.73
BGNE B -1.53 3.59
ARGX D -3.15 3.52
IOVA C -2.50 3.51
GILD B -0.70 3.50
View All CNCR Holdings

Is CNCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.818
52 Week Low 26.17
Average Volume 4,867
200-Day Moving Average 31.12
50-Day Moving Average 30.01
20-Day Moving Average 30.92
10-Day Moving Average 30.93
Average True Range 0.61
ADX 11.4
+DI 23.48
-DI 22.80
Chandelier Exit (Long, 3 ATRs) 29.89
Chandelier Exit (Short, 3 ATRs) 31.76
Upper Bollinger Bands 31.47
Lower Bollinger Band 30.37
Percent B (%b) 0.57
BandWidth 3.53
MACD Line 0.31
MACD Signal Line 0.31
MACD Histogram -0.003
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.17
Resistance 3 (R3) 32.27 31.98 31.97
Resistance 2 (R2) 31.98 31.68 31.93 31.91
Resistance 1 (R1) 31.49 31.50 31.34 31.39 31.84
Pivot Point 31.20 31.20 31.13 31.15 31.20
Support 1 (S1) 30.71 30.90 30.56 30.61 30.15
Support 2 (S2) 30.42 30.72 30.37 30.09
Support 3 (S3) 29.93 30.42 30.02
Support 4 (S4) 29.83